Search

everythinglearnresearchcommunity

for

Search:↓

Clobetasol propionate 0.05% ointment is more effective than tacrolimus 0.1% ointment for treating alopecia areata.

A 5-year-old girl's scalp scarring and hair loss from lupus improved with specific medications.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Complete COVID-19 vaccination reduces the risk of long COVID.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

A PEG-400/oleic acid mixture best improves drug delivery monitoring through hair follicles.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

The patient had a severe allergic reaction to gold treatment.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Albumin and prednisone improved symptoms in a woman with Cronkhite-Canada syndrome, revealing potential genetic causes.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Early and accurate diagnosis is crucial for managing rare genetic disorders like this localized variant of junctional epidermolysis bullosa.

A 5-year-old girl with a rare skin disorder was effectively treated with skin creams instead of oral medication.

New treatments for chronic central serous chorioretinopathy show promise in preventing permanent vision loss.

Baricitinib is effective as a treatment for severe hair loss.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

The combination therapy was effective and well-tolerated, especially in young patients.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

New micelle solutions greatly improve skin delivery of certain antifungal drugs.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

A woman developed lupus after taking hydroxyurea for two years.